V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010612 | 310008081 | 1.88 | 77.5 | Curative (C) | 2017-12-05 | 2017-12-05 | ESHAP | 2 | N | 310019038 | CARBOPLATIN + ETOPOSIDE |
| 310010613 | 310004839 | 1.6 | 67.9 | Curative (C) | 2016-11-24 | 2016-11-26 | ALL UKALL2011 (ProtM-A) C PegAsp | null | null | 310019048 | ESHAP |
| 310010614 | 310004842 | 1.58 | null | Curative (C) | 2015-02-19 | 2015-02-19 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 310019058 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310010615 | 310004848 | 1.77 | 67.7 | Palliative (P) | 2016-12-12 | 2016-12-12 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310019087 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310010617 | 310004854 | 0 | 74.6 | Curative (C) | 2016-08-24 | 2016-08-26 | ETOPOSIDE | N | N | 310019103 | ETOPOSIDE |
| 310010618 | 310004855 | 1.73 | 57.2 | Curative (C) | null | 2016-04-30 | Cisplatin | N | N | 310019116 | CISPLATIN |
| 310010619 | 310008094 | 1.6 | 55.2 | Curative (C) | 2016-06-01 | 2016-06-01 | Cyclophosphamide High Dose | 2 | N | 310019130 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010620 | 310008095 | 1.43 | 68.6 | null | 2016-10-02 | 2016-10-03 | Ipilimumab | N | N | 310019133 | IPILIMUMAB |
| 310010621 | 310004864 | 1.78 | 67.3 | null | 2014-09-27 | 2014-11-10 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 310019139 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310010622 | 310008099 | 1.76 | 29.7 | Curative (C) | null | 2014-04-06 | Cyclophosphamide High Dose | N | N | 310019167 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010623 | 310004875 | 1.57 | 73.9 | Curative (C) | 2015-05-28 | 2015-05-28 | Ipilimumab | N | N | 310019214 | IPILIMUMAB |
| 310010624 | 310009813 | null | 77.1 | Curative (C) | 2017-12-14 | 2018-06-22 | Methotrexate intrathecal | N | N | 310019216 | METHOTREXATE INTRATHECAL |
| 310010625 | 310008103 | 1.69 | 73.2 | Disease modification (D) | 2016-07-20 | 2016-07-26 | CARBOPLATIN + ETOPOSIDE | 02 | N | 310019225 | UKALL2011 |
| 310010626 | 310004881 | 1.89 | 74 | Neo-adjuvant (N) | 2011-02-14 | 2014-01-27 | GDP | N | N | 310019231 | GDP |
| 310010627 | 310004895 | null | 101.3 | Curative (C) | 2014-01-08 | 2014-06-18 | ALL UKALL2011 (ProtM-A) C PegAsp | N | N | 310019289 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310010628 | 310004895 | 1.6 | null | null | 2017-03-18 | 2017-03-18 | ETOPOSIDE | 02 | N | 310019289 | ETOPOSIDE |
| 310010630 | 310008112 | 1.77 | null | null | 2014-04-06 | 2015-11-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310019334 | BEXAROTENE |
| 310010631 | 310004906 | 1.75 | null | Disease modification (D) | 2017-01-23 | 2017-01-25 | Rituximab | Y | N | 310019357 | RITUXIMAB |
| 310010632 | 310008117 | 1.69 | null | Palliative (P) | 2016-05-11 | 2016-05-31 | Docetaxel | N | N | 310019360 | DOCETAXEL |
| 310010633 | 310004909 | 1.56 | null | Palliative (P) | 2016-03-18 | 2016-03-20 | Cyclophosphamide oral | 2 | N | 310019366 | CYCLOPHOSPHAMIDE |
| 310010634 | 310004912 | 0 | 81.65 | Palliative (P) | 2013-09-08 | 2013-09-09 | Cisplatin | N | N | 310019371 | CISPLATIN |
| 310010635 | 310008122 | 1.8 | 83.3 | Palliative (P) | 2017-01-10 | 2017-04-03 | Cyclophosphamide High Dose | N | N | 310019376 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010636 | 310004919 | 1.89 | 83.7 | Palliative (P) | 2016-06-19 | 2016-06-19 | Carboplatin + Etoposide iv&po | N | N | 310019388 | CARBOPLATIN + ETOPOSIDE |
| 310010637 | 310004923 | 1.68 | 96 | Palliative (P) | 2017-02-01 | 2017-03-05 | Docetaxel 100mg/m2 (21 day) | 02 | N | 310019399 | DOCETAXEL |
| 310010638 | 310004929 | null | 57.6 | Curative (C) | null | 2015-07-07 | ESHAP | 2 | null | 310019427 | UKALL2011 |
| 310010639 | 310004930 | 1.77 | 90.5 | Palliative (P) | 2011-01-07 | 2015-03-17 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019432 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310010640 | 310004932 | 1.77 | 57.5 | Curative (C) | 2015-11-07 | 2016-02-18 | Rituximab | N | N | 310019457 | RITUXIMAB |
| 310010641 | 310004937 | 1.78 | 82.2 | null | 2014-02-04 | 2014-02-11 | ALL UKALL2011 Cap Int Maint C PAsp | 02 | N | 310019463 | CARBOPLATIN + ETOPOSIDE |
| 310010642 | 310004941 | 1.6 | 66.1 | Palliative (P) | 2016-03-31 | 2016-04-08 | Etoposide PBSCT Mobilisat (1.6g/m2) | 99 | N | 310019466 | ETOPOSIDE |
| 310010643 | 310004946 | 1.59 | 61.1 | Palliative (P) | 2015-08-26 | 2015-08-26 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310019473 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310010644 | 310004951 | 1.54 | 50.6 | Not known (9) | 2018-02-26 | 2018-02-26 | Cyclophosphamide High Dose | 2 | null | 310019477 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010645 | 310009830 | 1.69 | 77.9 | Palliative (P) | 2014-06-06 | 2014-06-14 | GDP | N | N | 310019484 | GDP |
| 310010646 | 310004955 | 1.65 | 69.9 | Palliative (P) | 2017-12-07 | 2017-12-08 | ETOPOSIDE | 02 | Y | 310019507 | ETOPOSIDE |
| 310010647 | 310004959 | 1.69 | 62 | Palliative (P) | null | 2017-10-07 | Cyclophosphamide oral | null | null | 310019511 | CYCLOPHOSPHAMIDE |
| 310010648 | 310004962 | 1.71 | 93.6 | null | 2016-12-31 | 2017-08-09 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019539 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310010650 | 310008151 | 1.77 | 54.8 | Palliative (P) | 2018-06-27 | 2018-08-04 | CYCLOPHOSPHAMIDE + FILGRASTIM | null | null | 310019545 | CYCLOPHOSPHAMIDE |
| 310010651 | 310008153 | 1.73 | 58 | Curative (C) | 2017-03-21 | 2017-07-10 | Bexarotene | 02 | N | 310019551 | ESHAP |
| 310010652 | 310004969 | 1.67 | 95 | Curative (C) | 2016-01-26 | 2016-01-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | 310019558 | DOCETAXEL |
| 310010653 | 310008157 | 1.56 | null | Curative (C) | 2018-04-09 | 2018-09-25 | Bexarotene | 02 | N | 310019563 | BEXAROTENE |
| 310010654 | 310004976 | 1.68 | 54.5 | Palliative (P) | 2017-06-12 | 2017-11-27 | Methotrexate High Dose (3g/m2) | 02 | N | 310019567 | HYDROXYCARBAMIDE |
| 310010656 | 310004981 | 1.75 | 97 | null | 2014-06-24 | 2014-06-26 | THALIDOMIDE | 02 | N | 310019583 | POUT TRIAL |
| 310010657 | 310010756 | 1.63 | 60 | Adjuvant (A) | 2017-12-16 | 2018-02-08 | EC | 02 | N | 310019585 | METHOTREXATE |
| 310010658 | 310004983 | 1.5 | 42.2 | null | 2015-09-11 | 2015-11-10 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE | N | N | 310019610 | RUXOLITINIB |
| 310010659 | 310004986 | 1.75 | 54.2 | Palliative (P) | 2016-07-23 | 2016-09-04 | Enzalutamide | N | N | 310019619 | CETUXIMAB |
| 310010660 | 310004989 | 1.7 | null | Adjuvant (A) | null | 2019-01-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 310019634 | VEMURAFENIB |
| 310010661 | 310011835 | 1.64 | 87 | Palliative (P) | 2014-12-04 | 2014-12-04 | Oxaliplatin + Modified de Gramont | 02 | N | 310019645 | NIVOLUMAB |
| 310010662 | 310004995 | null | null | Curative (C) | 2014-11-24 | 2015-04-19 | PEG INTERFERON | 2 | N | 310019675 | CAPECITABINE + IRINOTECAN |
| 310010663 | 310004997 | 1.54 | 62.3 | Palliative (P) | 2014-10-14 | 2014-10-14 | Cytarabine intrathecal | N | N | 310019677 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 310010664 | 310005003 | 1.69 | 83 | Palliative (P) | 2014-11-05 | 2014-11-06 | DABRAFENIB | 02 | N | 310019686 | CETUXIMAB |
| 310010666 | 310005011 | null | 98 | Palliative (P) | 2016-05-25 | 2016-05-25 | Bendamustine +/- Prednisolone | 2 | N | 310019697 | SUNITINIB |